THERE ARE signs of a stirring at the World Trade Organisation (WTO) to reinforce the battle against the COVID-19 pandemic. Fifteen long months after South Africa and India first proposed that WTO keep in abeyance its TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement that protects intellectual property rights (IPRS) SO medicines, vaccines and diagnostics to fight the SARS-COV-2 virus can be manufactured freely, the body suddenly appears to be in a hurry to arrive at a deal on the contentious plan.
In mid-January, WTO's general council held a meeting in response to India's call to hold a virtual ministerial conference to discuss the waiver. This could have been a reaction to the rapid spread of the Omicron variant of the virus and its subsets across the US, Europe and India. Reports from Brussels speak of secret parleys in Geneva involving the EU, US, India and South Africa at a senior political level, to thrash out a deal on the proposal that has been moribund since October 2020.
The waiver will allow generic manufacturers to override IPRS on medical products, especially vaccines, and make these available sufficiently across geographic locations at a much cheaper cost. This has become an imperative since Big Pharma, in particular Pfizer-BioNTech and Moderna, has been supplying its costly vaccines to rich nations and leaving the populations of poor countries in Africa, Asia and Latin America majorly unprotected. Experts say the new variants of the SARS-COV-2 virus have emerged on account of this.
Diese Geschichte stammt aus der February 16, 2022-Ausgabe von Down To Earth.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der February 16, 2022-Ausgabe von Down To Earth.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.